Krishna Vaddi, CEO at Prelude Therapeutics Inc (PRLD), bought 97,500 shares at $0.71 ($70K) on 2025-03-12, disclosed to the SEC on 2025-03-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.71 | 47,500 | $34K | 48.4% |
| 2 | $0.72 | 50,000 | $36K | 51.6% |
| Total | $0.72 avg | 97,500 | $70K | 100% |
| Filing → |
| PRLD | BUY | 2025-03-18 | $29K | — | Filing → |
| PRLD | BUY | 2025-01-03 | $6K | — | Filing → |
| PRLD | BUY | 2025-01-02 | $12K | — | Filing → |